Taking into consideration that C3 has only a high-mannose N-glycome and that there is an increasing evidence that the complement system plays an important role in T1D (4), we hypothesized that C3 N-glycosylation aberrations could provide a valuable biomarker of T1D pathophysiology. The gene discussed is C3; the disease is type 1 diabetes mellitus.